Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended   December 31, 2021September 30, 2022

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                    to                                     

 

Commission File Number: 000-12196

nve.jpg

NVE CORPORATION

(Exact name of registrant as specified in its charter)

 

Minnesota

 

41-1424202

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

11409 Valley View Road, Eden Prairie, Minnesota

 

55344 

(Address of principal executive offices)

 

(Zip Code)

 

(952) 829-9217 

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes  ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes  ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer ☐

 

Non-accelerated filer ☒

Smaller reporting company ☒

  

Emerging growth company ☐ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     ☐ Yes  ☒ No

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

NVEC

The NASDAQ Stock Market, LLC

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $0.01 Par Value – 4,833,7144,830,826 shares outstanding as of JanuaryOctober 14, 2022

 

 

 

 

NVE CORPORATION

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION

 
  

Item 1. Financial Statements

 
  

Balance Sheets

 
  

Statements of Income for the Quarters Ended December 31,September 30, 2022 and 2021

Statements of Comprehensive Income for the Quarters Ended September 30, 2022 and 20202021

Statements of Income for the Six Months Ended September 30, 2022 and 2021 
  

Statements of Comprehensive Income for the Quarters Ended December 31, 2021 and 2020

Statements of Income for the NineSix Months Ended December 31, 2021September 30, 2022 and 2020

Statements of Comprehensive Income for the Nine Months Ended December 31, 2021 and 2020

Statements of Shareholders’ Equity for the Period Ended December 31, 2021

 
  

Statements of Shareholders’ Equity for the PeriodSix Months Ended December 31, 2020September 30, 2022

Statements of Shareholders’ Equity for the Six Months Ended September 30, 2021

 
  

Statements of Cash Flows for the Six Months Ended September 30, 2022 and 2021

 
  

Notes to Financial Statements

 
  

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 
  

Item 4. Controls and Procedures

 
  

PART II. OTHER INFORMATION

 
  

Item 1. Legal Proceedings

 
  

Item 1A. Risk Factors

 
  

Item 4. Mine Safety Disclosures

 
  

Item 6. Exhibits

 
  

SIGNATURES

 
 

 

2

 

PART IFINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

 

NVE CORPORATION

BALANCE SHEETS

 

(Unaudited)

December 31, 2021

 

March 31,

2021*

  

(Unaudited)

September 30, 2022

 

March 31, 2022*

 

ASSETS

  

Current assets

  

Cash and cash equivalents

 $8,967,657  $10,427,340  $3,583,539  $10,449,510 

Marketable securities, short-term

 22,482,494  7,678,957  10,326,647  20,839,683 

Accounts receivable, net of allowance for uncollectible accounts of $15,000

 3,038,203  1,964,281  5,860,414  4,704,829 

Inventories

 4,367,675  3,900,777  5,794,849  5,088,635 

Prepaid expenses and other assets

  921,846   391,278   600,913   420,520 

Total current assets

  39,777,875   24,362,633   26,166,362   41,503,177 

Fixed assets

  

Machinery and equipment

 9,312,982  9,254,664  9,603,049  9,739,244 

Leasehold improvements

  1,810,872   1,810,872   1,826,334   1,810,872 
 11,123,854  11,065,536  11,429,383  11,550,116 

Less accumulated depreciation and amortization

  10,886,378   10,728,853   10,990,224   10,943,731 

Net fixed assets

 237,476  336,683  439,159  606,385 

Deferred tax assets

 260,134  73,538  894,045  483,469 

Marketable securities, long-term

 27,179,552  47,038,669  39,514,685  24,314,211 

Right-of-use asset – operating lease

  593,715   689,216   494,070   560,250 

Total assets

 $68,048,752  $72,500,739  $67,508,321  $67,467,492 
  

LIABILITIES AND SHAREHOLDERS’ EQUITY

  

Current liabilities

  

Accounts payable

 $111,243  $336,591  $399,263  $943,535 

Accrued payroll and other

 812,502  540,474  2,861,151  1,356,689 

Operating lease

  152,807   150,273   157,830   156,121 

Total current liabilities

 1,076,552  1,027,338  3,418,244  2,456,345 

Operating lease

  482,798   581,459   374,941   446,018 

Total liabilities

 1,559,350  1,608,797  3,793,185  2,902,363 
  

Shareholders’ equity

  

Common stock, $0.01 par value, 6,000,000 shares authorized; 4,833,714 issued and outstanding as of December 31, 2021 and 4,833,232 as of March 31, 2021

 48,337  48,332 

Common stock, $0.01 par value, 6,000,000 shares authorized; 4,830,826 issued and outstanding as of September 30 and March 31, 2022

 48,308  48,308 

Additional paid-in capital

 19,411,158  19,338,127  19,303,570  19,256,485 

Accumulated other comprehensive income

 433,759  1,101,119 

Accumulated other comprehensive (loss)

 (1,784,035) (318,120)

Retained earnings

  46,596,148   50,404,364   46,147,293   45,578,456 

Total shareholders’ equity

  66,489,402   70,891,942   63,715,136   64,565,129 

Total liabilities and shareholders’ equity

 $68,048,752  $72,500,739  $67,508,321  $67,467,492 

 

*The March 31, 20212022 Balance Sheet is derived from the audited financial statements contained in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021.2022.

 

See accompanying notes. 

 

3

 

 

NVE CORPORATION

STATEMENTS OF INCOME

(Unaudited)

 

 

Quarter Ended December 31

  

Quarter Ended September 30

 
 

2021

 

2020

  

2022

 

2021

 

Revenue

        

Product sales

 $5,916,790  $6,332,349  $10,514,539  $6,630,012 

Contract research and development

  374,019   201,013   203,285   193,450 

Total revenue

 6,290,809  6,533,362  10,717,824  6,823,462 

Cost of sales

  1,385,006   1,075,048   2,402,781   1,544,134 

Gross profit

 4,905,803  5,458,314  8,315,043  5,279,328 

Expenses

        

Research and development

 596,492  702,216  669,978  707,997 

Selling, general, and administrative

  272,159   311,356   435,625   483,116 

Total expenses

  868,651   1,013,572   1,105,603   1,191,113 

Income from operations

 4,037,152  4,444,742  7,209,440  4,088,215 

Interest income

  283,940   365,498   351,375   294,858 

Income before taxes

 4,321,092  4,810,240  7,560,815  4,383,073 

Provision for income taxes

  855,685   884,531   1,470,442   736,566 

Net income

 $3,465,407  $3,925,709  $6,090,373  $3,646,507 

Net income per share – basic

 $0.72  $0.81  $1.26  $0.75 

Net income per share – diluted

 $0.72  $0.81  $1.26  $0.75 

Cash dividends declared per common share

 $1.00  $1.00  $1.00  $1.00 

Weighted average shares outstanding

        

Basic

 4,833,604  4,833,232  4,830,826  4,833,232 

Diluted

 4,835,770  4,833,261  4,830,956  4,836,603 

 

 

STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

 

 

Quarter Ended December 31

  

Quarter Ended September 30

 
 

2021

 

2020

  

2022

 

2021

 

Net income

 $3,465,407  $3,925,709  $6,090,373  $3,646,507 

Unrealized loss from marketable securities, net of tax

  (380,161)  (145,452)  (1,127,362)  (197,034)

Comprehensive income

 $3,085,246  $3,780,257  $4,963,011  $3,449,473 

 

See accompanying notes.

 

4

NVE CORPORATION

STATEMENTS OF INCOME

(Unaudited)

 

 

Nine Months Ended December 31

 

Six Months Ended September 30

 

2021

 

2020

 

2022

 

2021

Revenue

     

Product sales

 $19,500,567  $14,850,157 $17,587,500 $13,583,778

Contract research and development

  766,866   653,252  466,731  392,847

Total revenue

 20,267,433  15,503,409  18,054,231 13,976,625

Cost of sales

  4,698,720   2,852,757  4,054,628  3,313,715

Gross profit

 15,568,713  12,650,652  13,999,603 10,662,910

Expenses

     

Research and development

 2,112,630  2,399,164  1,271,896 1,516,139

Selling, general, and administrative

  1,221,893   1,024,549  806,946  949,734

Total expenses

  3,334,523   3,423,713  2,078,842  2,465,873

Income from operations

 12,234,190  9,226,939  11,920,761 8,197,037

Interest income

  868,519   1,166,102  634,436  584,578

Income before taxes

 13,102,709  10,393,041  12,555,197 8,781,615

Provision for income taxes

  2,411,228   1,833,127  2,324,707  1,555,542

Net income

 $10,691,481  $8,559,914 $10,230,490 $7,226,073

Net income per share – basic

 $2.21  $1.77 $2.12 $1.50

Net income per share – diluted

 $2.21  $1.77 $2.12 $1.49

Cash dividends declared per common share

 $3.00  $3.00 $2.00 $2.00

Weighted average shares outstanding

     

Basic

 4,833,356  4,834,324  4,830,826 4,833,232

Diluted

 4,835,781  4,834,411    4,836,621

 

 

STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

 

 

Nine Months Ended December 31

  

Six Months Ended September 30

 
 

2021

 

2020

  

2022

 

2021

 

Net income

 $10,691,481  $8,559,914  $10,230,490  $7,226,073 

Unrealized (loss) gain from marketable securities, net of tax

  (667,361)  966,886 

Unrealized loss from marketable securities, net of tax

  (1,465,915)  (287,199)

Comprehensive income

 $10,024,120  $9,526,800  $8,764,575  $6,938,874 

 

See accompanying notes.

 

5

 

 

NVE CORPORATION

STATEMENTS OF SHAREHOLDERS EQUITY

(Unaudited)

 

             

Accumulated

                     

Accumulated

        
         

Additional

 

Other

                 

Additional

 

Other

        
 

Common Stock

 

Paid-In

 

Comprehensive

 

Retained

     

Common Stock

 

Paid-In

 

Comprehensive

 

Retained

    
 

Shares

  

Amount

  

Capital

  

Income

  

Earnings

  

Total

  

Shares

  

Amount

  

Capital

  

Income (Loss)

  

Earnings

  

Total

 

Balance as of March 31, 2021

 4,833,232  $48,332  $19,338,127  $1,101,119  $50,404,364  $70,891,942 

Balance as of March 31, 2022

 4,830,826  $48,308  $19,256,485  $(318,120) $45,578,456  $64,565,129 

Comprehensive income:

  

Unrealized loss on marketable securities, net of tax

        (90,165

)

    (90,165

)

     (338,553)  (338,553)

Net income

          3,579,566   3,579,566       4,140,116  4,140,116 

Total comprehensive income

            3,489,401         3,801,563 

Stock-based compensation

      7,238       7,238     7,134   7,134 

Cash dividends declared ($1.00 per share of common stock)

                  (4,833,232

)

  (4,833,232

)

           (4,830,826)  (4,830,826)

Balance as of June 30, 2021

  4,833,232   48,332   19,345,365   1,010,954   49,150,698   69,555,349 
Balance as of June 30, 2022  4,830,826  48,308  19,263,619  (656,673)  44,887,746  63,543,000 

Comprehensive income:

  

Unrealized loss on marketable securities, net of tax

   0 0  (197,034) 0  (197,034)      (1,127,362

)

   (1,127,362

)

Net income

   0 0 0  3,646,507   3,646,507        6,090,373   6,090,373 

Total comprehensive income

   0 0 0 0  3,449,473          4,963,011 

Stock-based compensation

   0  56,999  0 0  56,999      39,951     39,951 

Cash dividends declared ($1.00 per share of common stock)

      0   0   0   (4,833,232)  (4,833,232)               (4,830,826

)

  (4,830,826

)

Balance as of September 30, 2021

  4,833,232   48,332   19,402,364   813,920   47,963,973   68,228,589 
Exercise of stock options 482  5 (5) 0 0 0

-

 
Comprehensive income:              
Unrealized loss on marketable securities, net of tax    0 0 (380,161) 0 (380,161)
Net income    0 0 0 3,465,407   3,465,407 
Total comprehensive income    0 0 0 0 3,085,246 
Stock-based compensation    0 8,799 0 0 8,799 
Cash dividends declared ($1.00 per share of common stock)      0  0  0  (4,833,232)  (4,833,232)
Balance as of December 31, 2021  4,833,714  $48,337 $19,411,158 $433,759 $46,596,148 $66,489,402 

Balance as of September 30, 2022

  4,830,826  $48,308  $19,303,570  $(1,784,035) $46,147,293  $63,715,136 

 

See accompanying notes. 

 

6

 

 

NVE CORPORATION

STATEMENTS OF SHAREHOLDERS EQUITY

(Unaudited)

 

             

Accumulated

                     

Accumulated

        
         

Additional

 

Other

                 

Additional

 

Other

        
 

Common Stock

 

Paid-In

 

Comprehensive

 

Retained

     

Common Stock

 

Paid-In

 

Comprehensive

 

Retained

    
 

Shares

  

Amount

  

Capital

  

Income

  

Earnings

  

Total

  

Shares

  

Amount

  

Capital

  

Income (Loss)

  

Earnings

  

Total

 

Balance as of March 31, 2020

 4,835,038  $48,350  $19,383,956  $516,523  $58,046,520  $77,995,349 

Comprehensive income:

 

Unrealized gain on marketable securities, net of tax

   0 0  1,242,662  0  1,242,662 

Net income

   0 0 0  2,411,865   2,411,865 

Total comprehensive income

   0 0 0 0  3,654,527 

Stock-based compensation

   0  2,707  0 0  2,707 

Cash dividends declared ($1.00 per share of common stock)

      0   0   0   (4,835,038

)

  (4,835,038

)

Balance as of June 30, 2020

  4,835,038   48,350   19,386,663   1,759,185   55,623,347   76,817,545 

Repurchase of common stock

 (1,806

)

 (18

)

 (91,401

)

 0 0  (91,401

)

Balance as of March 31, 2021

 4,833,232  $48,332  $19,338,127  $1,101,119  $50,404,364  $70,891,942 

Comprehensive income:

  

Unrealized loss on marketable securities, net of tax

   0 0  (130,324

)

    (130,324

)

       (90,165

)

    (90,165

)

Net income

   0 0 0  2,222,340   2,222,340          3,579,566   3,579,566 

Total comprehensive income

            2,092,016              3,489,401 

Stock-based compensation

      34,315       34,315       7,238       7,238 

Cash dividends declared ($1.00 per share of common stock)

                  (4,835,038

)

  (4,835,038

)

                (4,833,232)  (4,833,232)

Balance as of September 30, 2020

  4,833,232   48,332   19,329,577   1,628,861   53,010,649   74,017,419 
Balance as of June 30, 2021  4,833,232  48,332   19,345,365   1,010,954  49,150,698   69,555,349 
Comprehensive income:                 
Unrealized loss on marketable securities, net of tax   0 0 (145,452) 0 (145,452)       (197,034)   (197,034)
Net income   0 0 0 3,925,709   3,925,709         3,646,507   3,646,507 
Total comprehensive income   0 0 0 0 3,780,257            3,449,473 
Stock-based compensation   0 4,275 0 0 4,275      56,999     56,999 
Cash dividends declared ($1.00 per share of common stock)     0  0  0  (4,833,232)  (4,833,232)               (4,833,232

)

  (4,833,232

)

Balance as of December 31, 2020  4,833,232 $48,332 $19,333,852 $1,483,409 $52,103,126 $72,968,719 

Balance as of September 30, 2021

  4,833,232  $48,332  $19,402,364  $813,920  $47,963,973  $68,228,589 

 

See accompanying notes. 

 

7

 

 

NVE CORPORATION

STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

Nine Months Ended December 31

  

Six Months Ended September 30

 
 

2021

  

2020

  

2022

  

2021

 

OPERATING ACTIVITIES

  

Net income

 $10,691,481  $8,559,914  $10,230,490  $7,226,073 

Adjustments to reconcile net income to net cash provided by operating activities:

  

Depreciation and amortization

 358,828  386,968  158,851  271,207 

Stock-based compensation

 73,036  41,297  47,085  64,237 

Deferred income taxes

 319  (73,269) -  16,539 

Changes in operating assets and liabilities:

  

Accounts receivable

 (1,073,922) (467,290) (1,155,585) (911,821)

Inventories

 (466,898) 41,973  (706,214) 81,994 

Prepaid expenses and other assets

 (435,067) 181,557  (114,213) (298,099)

Accounts payable and other liabilities

  (49,447)  (140,082)

Accounts payable and accrued expenses

  890,822   172,054 

Net cash provided by operating activities

  9,098,330   8,531,068   9,351,238   6,458,196 
  

INVESTING ACTIVITIES

  

Purchases of fixed assets

 (58,317) 0(13,627) (24,500) (73,916)

Purchases of marketable securities

  (25,381,057)  - 

Proceeds from maturities of marketable securities

  4,000,000   12,000,000   18,750,000   4,000,000 

Cash provided by investing activities

  3,941,683   11,986,373 
Receipt of tenant improvement allowance  100,000   - 

Net cash provided (used) by investing activities

  (6,555,557)   3,926,084 
  

FINANCING ACTIVITIES

  
Repurchase of common stock  0   (91,419)

Payment of dividends to shareholders

  (14,499,696)  (14,503,308)  (9,661,652)  (9,666,464)

Cash used in financing activities

  (14,499,696)  (14,594,727)  (9,661,652)  (9,666,464)

(Decrease) increase in cash and cash equivalents

 (1,459,683) 5,922,714  (6,865,971) 717,816 
  

Cash and cash equivalents at beginning of period

  10,427,340   8,065,594   10,449,510   10,427,340 
  

Cash and cash equivalents at end of period

 $8,967,657  $13,988,308  $3,583,539  $11,145,156 
  

Supplemental disclosures of cash flow information:

  

Cash paid during the period for income taxes

 $2,490,000  $1,636,788  $1,281,629  $1,760,000 

 

See accompanying notes. 

 

8

 

NVE CORPORATION

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

 

 

NOTE 1. DESCRIPTION OF BUSINESS

We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. 

 

NOTE 2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited financial statements of NVE Corporation are prepared consistent with accounting principles generally accepted in the United States and in accordance with Securities and Exchange Commission rules and regulations. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal and recurring adjustments, necessary for a fair presentation of the financial statements. Although we believe that the disclosures are adequate to make the information presented not misleading, certain disclosures have been omitted as allowed, and it is suggested that these unaudited financial statements be read in conjunction with the audited financial statements and the notes included in our latest annual financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021.2022. The results of operations for the quarter and ninesix months ended December 31, 2021September 30, 2022 are not necessarily indicative of the results that may be expected for the full fiscal year ending March 31, 2022.2023.

 

Significant accounting policies

A description of our significant accounting policies is provided in Note 2 to the Financial Statements in our Annual Report on Form 10-K for the year ended March 31, 2021.2022. As of December 31, 2021,September 30, 2022, there were no changes to our significant accounting policies.

 

NOTE 3. RECENTLY ISSUED ACCOUNTING STANDARDS

Recently Adopted Accounting Standard

In December 2019,May 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes. ASU 2019-12 simplifies accounting for income taxes, removes certain exceptions to the general principles in Topic 740, and amends existing guidance to improve consistent application. We adopted ASU 2019-12 beginning with the quarter ended June 30, 2021. The adoption had no material impact on our financial statements.
 

New Accounting Standard Not Yet Adopted

In May 2021, the FASB issued ASU No.2021-04, Earnings Per Share (Topic 260), DebtDebt—Modifications and Extinguishments (Subtopic 470-50), CompensationCompensation—Stock Compensation (Topic 718), and Derivatives and HedgingHedging—Contracts in EntitysEntity’s Own Equity (Subtopic 815-40) IssuersIssuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU 2021-04 addresses issuer’sissuers’ accounting for certain modifications or exchanges of freestanding equity-classified written call options. We adopted ASU 2021-04 beginning with the quarter ended June 30,2022. The adoption had no material impact on our financial statements.
 

New Accounting Standard Not Yet Adopted

In June 2016, the FASB issued ASU No.2016-13,Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Statements. ASU 2016-13 requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. In November 2018 the FASB issued ASU No.2018-19,Codification Improvements to Topic326, Financial Instruments-Credit Losses, which clarifies codification and corrects unintended application of the guidance, and in November 2019, the FASB issued ASU No.2019-11,Codification Improvements to Topic 326, Financial Instruments-Credit Losses, which clarifies or addresses specific issues about certain aspects of ASU 2016-13. In November 2019 the FASB issued ASU No.2019-10,Financial InstrumentsCredit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates, and in February 2020 the FASB issued ASU No.2020-02,Financial InstrumentsCredit Losses (Topic326) and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No.119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No.2016-02, Leases (Topic 842), both of which delay the effective date of ASU 2016-13 by three years for certain Smaller Reporting Companies such as us. In March 2020, the FASB issued ASU No.2020-03,Codification Improvements to Financial Instruments; which modifies the measurement of expected credit losses of certain financial instruments. In accordance with ASU 2019-10 and ASU 2020-02, ASU 2016-13is effective for certain Smaller Reporting Companies for financial statements issued for fiscal years beginning after December 15, 2021 2022and interim periods within those fiscal years, which iswill be fiscal 20232024 for us if we continue to be classified as a Smaller Reporting Company, with early adoption permitted. We doare evaluating the potential impact of ASU not2016 expect adoption of the new guidance to have a significant impact-13 on our financial statements.

 

 

NOTE 4. NET INCOME PER SHARE

Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each period. Net income per diluted share amounts assume exercise of all stock options. The following tables show the components of diluted shares:

 

 

Quarter Ended December 31

 Quarter Ended September 30
 

2021

 

2020

 

2022

 

2021

Weighted average common shares outstanding – basic

 4,833,604  4,833,232 4,830,826 4,833,232

Dilutive effect of stock options

  2,167   29 130 3,371

Shares used in computing net income per share – diluted

  4,835,770   4,833,261 4,830,956 4,836,603
Six Months Ended September 30
2022 2021
Weighted average common shares outstanding – basic4,830,826 4,833,232
Dilutive effect of stock options101 3,389
Shares used in computing net income per share – diluted4,830,927 4,836,621

 

  

Nine Months Ended December 31

 
  

2021

  

2020

 

Weighted average common shares outstanding – basic

  4,833,356   4,834,324 

Dilutive effect of stock options

  2,425   87 

Shares used in computing net income per share – diluted

  4,835,781   4,834,411 

 

9

 

NOTE 5. FAIR VALUE OF FINANCIAL INSTRUMENTS

Our corporate bonds and money market funds are classified as available-for-sale securities and carried at estimated fair value. Unrealized holding gains and losses are included in accumulated other comprehensive income (loss) in the statement of shareholders’ equity. Corporate bonds with remaining maturities less than one year are classified as short-term, and those with remaining maturities greater than one year are classified as long-term. We consider all highly-liquid investments with maturities of three months or less when purchased, including money market funds, to be cash equivalents. Gains and losses on marketable security transactions are reported on the specific-identification method.

 

Contractual maturities of available-for-sale securities as of December 31, 2021September 30, 2022 are as follows: 

 

Total

Total

  

<1 Year

 

1–3 Years

 

3–5 Years

 

Total

 

<1 Year

 

1–3 Years

 

3–7 Years

 
$57,293,870  $30,114,318  $22,148,686  $5,030,866 51,598,609 $12,083,924 $24,387,794 $15,126,891 

 

Total available-for-sale securities represented approximately 84%76% of our total assets. Marketable securities as of December 31, 2021September 30, 2022 had remaining maturities between three14 weeks and 3879 months.

 

Generally accepted accounting principles establish a framework for measuring fair value, provide a definition of fair value, and prescribe required disclosures about fair-value measurements. Generally accepted accounting principles define fair value as the price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Generally accepted accounting principles utilize a valuation hierarchy for disclosure of fair value measurements. The categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The categories within the valuation hierarchy are described as follows:

Level 1 – Financial instruments with quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Financial instruments with quoted prices in active markets for similar assets or liabilities. Level 2 fair value measurements are determined using either prices for similar instruments or inputs that are either directly or indirectly observable, such as interest rates.

 

Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques.

 

Money market funds are included on the balance sheets in “Cash and cash equivalents.” Corporate bonds are included on the balance sheets in “Marketable securities, short term” and “Marketable securities, long term.”

 

The following table shows the estimated fair value of assets that were accounted for at fair value on a recurring basis:

 

 

As of December 31, 2021

 

As of March 31, 2021

  

As of September 30, 2022

 

As of March 31, 2022

 

Level 1

 

Level 2

 

Total

 

Level 1

 

Level 2

 

Total

  

Level 1

 

Level 2

 

Total

 

Level 1

 

Level 2

 

Total

Money market funds

 $7,631,824  $0  $7,631,824  $10,143,196  $0  $10,143,196  $1,757,277  $-  $1,757,277  $6,756,993  $-  $6,756,993

Corporate bonds

  0   49,662,046   49,662,046   0   54,717,626   54,717,626   -   49,841,332   49,841,332   -   45,153,894   45,153,894

Total

 $7,631,824  $49,662,046  $57,293,870  $10,143,196  $54,717,626  $64,860,822  $1,757,277  $49,841,332  $51,598,609  $6,756,993  $45,153,894  $51,910,887

 

Our available-for-sale securities as of December 31September 30 and March 31, 2021,2022, aggregated into classes of securities, were as follows:

 

 

As of December 31, 2021

 

As of March 31, 2021

  

As of September 30, 2022

 

As of March 31, 2022

 

Amortized

Cost

 

Gross

Unrealized

Holding

Gains

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

 

Amortized

Cost

 

Gross

Unrealized

Holding

Gains

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

  

Amortized

Cost

 

Gross

Unrealized

Holding

Gains

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

 

Amortized

Cost

 

Gross

Unrealized

Holding

Gains

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

Money market funds

 $7,631,824  $0  $0  $7,631,824  $10,143,196  $0  $0  $10,143,196  $1,757,277  $-  $-  $1,757,277  $6,756,993  $-  $-  $6,756,993

Corporate bonds

  49,106,800   772,080   (216,834)  49,662,046   53,308,105   1,570,195   (160,674

)

  54,717,626   52,125,043   -   (2,283,711)  49,841,332   45,561,114   230,085   (637,305

)

  45,153,894

Total

 $56,738,624  $772,080  $(216,834) $57,293,870  $63,451,301  $1,570,195  $(160,674

)

 $64,860,822  $53,882,320  $-  $(2,283,711) $51,598,609  $52,318,107  $230,085  $(637,305

)

 $51,910,887

 

10

 

The following table shows the gross unrealized holding losses and fair value of our available-for-sale securities with unrealized holding losses, aggregated by class of securities and length of time that individual securities had been in a continuous unrealized loss position as of December 31, 2021September 30 and March 31, 2021.2022.

 

 

Less Than 12 Months

 

12 Months or Greater

 

Total

  

Less Than 12 Months

 

12 Months or Greater

 

Total

 
 

Estimated

Fair

Value

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

 

Gross

Unrealized

Holding

Losses

  

Estimated

Fair

Value

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

 

Gross

Unrealized

Holding

Losses

 

Estimated

Fair

Value

 

Gross

Unrealized

Holding

Losses

 
  

As of December 31, 2021

            

As of September 30, 2022

            

Corporate bonds

 $10,167,905  $(216,834) $0  $0  $10,167,905  $(216,834) $40,510,241  $(1,327,302) $9,331,091  $(956,409) $49,841,332  $(2,283,711)

Total

 $10,167,905  $(216,834) $0  $0  $10,167,905  $(216,834) $40,510,241  $(1,327,302) $9,331,091  $(956,409) $49,841,332  $(2,283,711)
  

As of March 31, 2021

            

As of March 31, 2022

            

Corporate bonds

 $10,322,539  $(160,674

)

 $0  $0  $10,322,539  $(160,674

)

 $6,306,750  $(23,727

)

 $9,738,338  $(613,578) $16,045,088  $(637,305

)

Total

 $10,322,539  $(160,674

)

 $0  $0  $10,322,539  $(160,674

)

 $6,306,750  $(23,727

)

 $9,738,338  $(613,578) $16,045,088  $(637,305

)

 

We did not consider any of our available-for-sale securities to be impaired as of December 31, 2021. None of the securities were impaired at acquisition, and subsequent declines in fair value are not attributed to declines in credit quality. The effects of the COVID-19 pandemic, however, have degraded outlooks for some of our marketable securities’ issuers, which could lead to credit-quality downgrades in the future. When evaluating for impairment we assess indicators that include, but are not limited to, earnings performance, changes in underlying credit ratings, market conditions, bona fide offers to purchase or sell, and ability to hold until maturity. Because we believe it is more likely than not we will recover the cost basis of our investments, we did not consider any of our marketable securities to be impaired as of December 31, 2021.September 30, 2022.

 

NOTE 6. INVENTORIES

Inventories are shown in the following table:

 

  

December 31,

2021

  

March 31,

2021

 

Raw materials

 $784,004  $660,678 

Work in process

  2,812,910   2,220,723 

Finished goods

  770,760   1,019,376 

Total inventories

 $4,367,675  $3,900,777 

  September 30, 2022  March 31, 2022

Raw materials

$1,324,358 $987,062

Work in process

 3,829,498  3,355,838

Finished goods

 640,993  745,735

Total inventories

$5,794,849 $5,088,635
 

NOTE 7. STOCK-BASED COMPENSATION

Stock-based compensation expense was $8,799$39,951 for the thirdsecond quarter of fiscal 2023, $56,999 for the second quarter of fiscal 2022, $4,275 for the third quarter of fiscal 2021, $73,036$47,085 for the first ninesix months of fiscal 2022,2023, and $41,297$64,237 for the first ninesix months of fiscal 2021.2022. We calculate the share-based compensation expense using the Black-Scholes standard option-pricing model.

 

NOTE 8. INCOME TAXES

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Federal and state income taxes payable as of September 30,2022 of approximately $1,457,000 are included in accrued expenses.

 

We had 0no unrecognized tax benefits as of December 31, 2021,September 30, 2022, and we do not expect any significant unrecognized tax benefits within 12 months of the reporting date. We recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2021September 30, 2022 we had 0no accrued interest related to uncertain tax positions. The tax years 20162018 through 20202022 remain open to examination by the major taxing jurisdictions to which we are subject. 

 

11

 

NOTE 9. LEASES

We conduct our operations in a leased facility under a non-cancellable lease expiring March 31, 2026. Our lease does not provide an implicit rate, so we used our incremental borrowing rate to determine the present value of lease payments. Lease expense is recognized on a straight-line basis over the lease term. Variable lease costs consist primarily of common area maintenance and real estate taxes which are paid based on actual costs incurred by the lessor. Details of our operating lease are as follows: 

 

 Quarter Ended
Dec. 31, 2021
  Nine Months Ended
Dec. 31, 2021
 Quarter Ended September 30, 2022  Six Months Ended September 30, 2022
Operating lease cost $42,516  $127,546 $42,515 $85,031 
Variable lease cost  31,029   93,087  30,126  61,315 
Total $73,545  $220,633 $72,641 $146,346 
      
Cash paid for amounts included in the measurement of lease liabilities      
Operating cash flows for leases $37,962  $113,886 $42,723 87,156 
Remaining lease term 51 months   42 months   
Discount rate 3.5%    3.5%   

 

 The following table presents the maturities of lease liabilities as of December 31, 2021:September 30, 2022:

 

Year Ending March 31 Operating Leases 
2022  38,817 
2023  156,121 
2024  159,592 
2025  163,224 
2026  165,947 
Total lease payments  683,701 
Imputed lease interest  (48,096)
Total lease liabilities $635,605 

Year Ending March 31Operating Leases 
2023 78,487 
2024 159,592 
2025 163,224 
2026 165,947 
Total lease payments 567,250 
Imputed lease interest (34,479)
Total lease liabilities$532,771 
 

NOTE 10. STOCK REPURCHASE PROGRAM

On January 21, 2009 we announced that our Board of Directors authorized the repurchase of up to $2,500,000 of our Common Stock from time to time in open market, block, or privately negotiated transactions. The timing and extent of any repurchases depends on market conditions, the trading price of the company’s stock, and other factors, and subject to the restrictions relating to volume, price, and timing under applicable law. On August 27, 2015, we announced that our Board of Directors authorized up to $5,000,000 of additional repurchases. Our repurchase program does not have an expiration date and does not obligate us to purchase any shares. The Program may be modified or discontinued at any time without notice. We intend to finance any stock repurchases with cash provided by operating activities or maturating marketable securities. The remaining authorization was $3,762,040$3,598,519 as of December 31, 2021.September 30, 2022. We havedid not repurchasedrepurchase any of our Common Stock during the firstsix months of fiscal 2022.2023.

 

 

NOTE 11. INFORMATION AS TO EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS

All of our employees are eligible to participate in our 401(k) savings plan the first quarter after reaching age 21. Employees may contribute up to the Internal Revenue Code maximum. We make matching contributions of 100% of the first 3% of participants’ salary deferral contributions. Our matching contributions were $21,57923,751 for the thirdsecond quarter of fiscal 2023, $26,831 for the second quarter of fiscal 2022, $22,571 for the third quarter of fiscal 2021, $76,995$52,177 for the first ninesix months of fiscal 2022,2023, and $69,227$55,415 for the first ninesix months of fiscal 2021.2022.

 

NOTE 12. SUBSEQUENT EVENTS

On JanuaryOctober 19, 2022 we announced that our Board had declared a quarterly cash dividend of $1.00 per share of Common Stock to be paid February 28,November 30, 2022 to shareholders of record as of the close of business JanuaryOctober 31, 2022.

 

12

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-looking statements

Some of the statements made in this Report or in the documents incorporated by reference in this Report and in other materials filed or to be filed by us with the Securities and Exchange Commission (“SEC”) as well as information included in verbal or written statements made by us constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor provisions of the reform act. Forward-looking statements may be identified by the use of the terminology such as may, will, expect, anticipate, intend, believe, estimate, should, or continue, or the negatives of these terms or other variations on these words or comparable terminology. To the extent that this Report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of NVE, you should be aware that our actual financial condition, operating results and business performance may differ materially from that projected or estimated by us in the forward-looking statements. We have attempted to identify, in context, some of the factors that we currently believe may cause actual future experience and results to differ from their current expectations. These differences may be caused by a variety of factors, including but not limited to risks related to our reliance on several large customers for a significant percentage of revenue, our dependence on critical suppliers and packaging vendors, uncertainties related to the economic environments in the industries we serve, uncertainties related to future sales and revenues, risks and uncertainties related to future stock repurchases and dividend payments, and other specific risks that may be alluded to in this Report or in the documents incorporated by reference in this Report.

 

Further information regarding our risks and uncertainties are contained in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended March 31, 2021 as updated in Item 1A of this report.2022.

 

General

NVE Corporation, referred to as NVE, we, us, or our, develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. We manufacture high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.

 

Critical accounting policies

A description of our critical accounting policies is provided in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended March 31, 2021.2022. As of December 31, 2021September 30, 2022 our critical accounting policies and estimates continued to include investment valuation, inventory valuation, and deferred tax assets estimation.

 

13

 

Quarter ended December 31, 2021September 30, 2022 compared to quarter ended December 31, 2020

September 30, 2021

The table shown below summarizes the percentage of revenue and quarter-to-quarter changes for various items:

 

 

Percentage of Revenue

Quarter Ended December 31

 

Quarter-

to-Quarter

 

Percentage of Revenue

Quarter Ended September 30

  

Quarter-

to-Quarter

 
 

2021

 

2020

 

Change

 

2022

  

2021

  

Change

 

Revenue

            

Product sales

  94.1

%

 96.9

%

  (6.6)

%

 98.1

%

 97.2

%

 58.6

%

Contract research and development

   5.9

%

   3.1

%

  86.1

%

1.9

%

 2.8

%

  5.1

%

Total revenue

 100.0

%

 100.0

%

  (3.7)

%

100.0

%

 100.0

%

 57.1

%

Cost of sales

   22.0

%

   16.5

%

  28.8

%

 22.4

%

  22.6

%

  55.6

%

Gross profit

  78.0

%

  83.5

%

  (10.1)

%

 77.6

%

  77.4

%

 57.5

%

Expenses

  

Research and development

  9.5

%

 10.7

%

  (15.1)

%

6.2

%

 10.4

%

  (5.4)

%

Selling, general, and administrative

   4.3

%

   4.8

%

  (12.6)

%

 4.1

%

  7.1

%

  (9.8)

%

Total expenses

   13.8

%

   15.5

%

  (14.3)

%

 10.3

%

  17.5

%

  (7.2)

%

Income from operations

  64.2

%

  68.0

%

  (9.2)

%

 67.3

%

 59.9

%

 76.3

%

Interest income

   4.5

%

   5.6

%

  (22.3)

%

 3.2

%

  4.3

%

 19.2

%

Income before taxes

  68.7

%

  73.6

%

  (10.2)

%

70.5

%

  64.2

%

 72.5

%

Provision for income taxes

   13.6

%

   13.5

%

  (3.3)

%

 13.7

%

  10.8

%

 99.6

%

Net income

   55.1

%

  60.1

%

  (11.7)

%

 56.8

%

 53.4

%

 67.0

%

 

Total revenue for the quarter ended December 31, 2021September 30, 2022 (the thirdsecond quarter of fiscal 2022) decreased 4%2023) increased 57% compared to the quarter ended December 31, 2020September 30, 2021 (the thirdsecond quarter of fiscal 2021)2022). The decreaseincrease was due to a 7% decrease59% increase in product sales partially offset by an 86%and a 5% increase in contract research and development revenue.

The decreaseincrease in product sales in the third quarter of fiscal 2022 from the prior-year quarter was primarily due to raw materials shortagesincreased purchases by existing customers and longer lead-times for critical materialsnew customers. Sales increased in most of our markets and services.product lines. The increase in contract research and development revenue was due to new contracts.

 

Gross profit as a percentageTotal expenses decreased 7% for the second quarter of revenue decreasedfiscal 2023 compared to 78% the thirdsecond quarter of fiscal 2022 from 84% the third quarter of fiscal 2021 primarily due to revenue mix and increased costs.

Total expenses decreased 14% in the third quarter of fiscal 2022 compared to the third quarter of fiscal 2021 due to a 15%5% decrease in research and development expense and a 13%10% decrease in selling, general, and administrative expense. The decreasedecreases in research and development expense wasexpenses were primarily due to staffing changes and the completionreallocation of certain product developmentresources to revenue-generating activities. The decrease in selling, general, and administrative expense was primarily due to staffing changes.

 

Interest income for the thirdsecond quarter of fiscal 2022 decreased 22%2023 increased 19% due to a decreasean increase in our available-for-sale securities and a decreasean increase in thetheir average interest rates on those securities.rate.

 

The 12% decrease67% increase in net income in the thirdsecond quarter of fiscal 20222023 compared to the prior-year quarter was primarily due to decreasedincreased revenue decreased gross margin, and decreased interest income partially offset by decreased expenses.

 

14

 

NineSix months ended December 31, 2021September 30, 2022 compared to ninesix months ended December 31, 2020

September 30, 2021

The table shown below summarizes the percentage of revenue and quarter-to-quarterperiod-to-period changes for various items:

 

 

Percentage of Revenue

Nine Months Ended December 31

 

Period-

to-Period

 

Percentage of Revenue

Six Months Ended September 30

  

Period-

to-Period

 
 

2021

 

2020

 

Change

 

2022

  

2021

  

Change

 

Revenue

            

Product sales

  96.2

%

 95.8

%

  31.3

%

 97.4

%

 97.2

%

 29.5

%

Contract research and development

   3.8

%

   4.2

%

  17.4

%

2.6

%

 2.8

%

  18.8

%

Total revenue

 100.0

%

  100.0

%

  30.7

%

100.0

%

 100.0

%

 29.2

%

Cost of sales

   23.2

%

  18.4

%

  64.7

%

 22.5

%

  23.7

%

 22.4

%

Gross profit

  76.8

%

 81.6

%

  23.1

%

 77.5

%

  76.3

%

 31.3

%

Expenses

  

Research and development

  10.4

%

 15.5

%

  (11.9)

%

 7.0

%

 10.9

%

  (16.1)

%

Selling, general, and administrative

   6.0

%

   6.6 

%

  19.3

%

4.5

%

  6.8

%

  (15.0)

%

Total expenses

   16.4

%

   22.1

%

  (2.6)

%

 11.5

%

  17.7

%

  (15.7)

%

Income from operations

  60.4

%

  59.5

%

  32.6

%

 66.0

%

 58.6

%

 45.4

%

Interest income

   4.2

%

   7.5

%

  (25.5)

%

 3.5

%

  4.2

%

 8.5

%

Income before taxes

 64.6

%

 67.0

%

  26.1

%

 69.5

%

  62.8

%

 43.0

%

Provision for income taxes

   11.8

%

  11.8

%

  31.5

%

 12.8

%

  11.1

%

 49.4

%

Net income

   52.8

%

  55.2

%

  24.9

%

 56.7

%

 51.7

%

 41.6

%

 

Total revenue for the ninesix months ended December 31, 2021September 30, 2022 (the first six months of fiscal 2023) increased 31%29% compared to the ninesix months ended December 31, 2020.September 30, 2021 (the first six months of fiscal 2022). The increase was due to a 31%29% increase in product sales and a 17%19% increase in contract research and development revenue.

The increase in product sales from the prior-year period was primarily due to increased purchases by existing customers and salesnew customers. Sales increased in most of our markets and product lines. The increase in contract research and development revenue was due to new contracts.

 

Gross profit as a percentage of revenue decreasedincreased to 77%78% for the first ninesix months of fiscal 2023 from 76% for the first six months of fiscal 2022 from 82% for the first nine months of fiscal 2021 primarily due to revenue mix andincreased prices partially offset by increased costs.

 

Total expenses decreased 3%16% for the first ninesix months of fiscal 2023 compared to the first six months of fiscal 2022 compared to the first nine months of fiscal 2021 due to a 12%16% decrease in research and development expense partially offset byand a 19% increase15% decrease in selling, general, and administrative expense. The decreasedecreases in research and development expense wasexpenses were primarily due to staffing changes and the completionreallocation of certain product developmentresources to revenue-generating activities. The increase in selling, general, and administrative expense was primarily due to increased employee compensation expense.

 

Interest income for the first ninesix months of fiscal 2022 decreased 26%2023 increased 9% due to a decreasean increase in our available-for-sale securities and a decreasean increase in thetheir average interest rates on those securities.rate.

 

The 25% 42% increase in net income in the first ninesix months of fiscal 20222023 compared to the prior-year period was primarily due to an increase in product sales.increased revenue and decreased expenses.

 

The Impact of the COVID-19 PandemicSupply Chain Disruptions

We believe the impact ofSupply chain disruptions related to the COVID-19 pandemic on customer demand was significantly lessmay have favorably affected product sales in the quarter and ninesix months ended December 31, 2021 compared toSeptember 30, 2022 since we believe the prior-year periods.disruptions may have been less severe for us than for our competitors. We believe thesupply chain disruptions also had an unfavorable impact of the pandemic on our supply chain, however, was significantly more in the quarter and nine months ended December 31, 2021 than in the prior-year periods. The effectscosts of the pandemic also increased labor and materials costs and expenses for the quarter and nine months ended December 31, 2021.sales.

 

15

Liquidity and Capital Resources

 

Overview

Cash and cash equivalents were $8,967,657$3,583,539 as of December 31, 2021September 30, 2022 compared to $10,427,340$10,449,510 as of March 31, 2021.2022. The $1,459,683$6,865,971 decrease in cash and cash equivalents during the first ninesix months of fiscal 20222023 was due to $14,499,696$9,661,652 of cash used in financing activities for dividend payments and $6,555,557 of cash used by investing activities, partially offset by $9,098,330$9,351,238 in net cash provided by operating activities and $3,941,683 of cash provided by investing activities.

 

Operating Activities

Net cash provided by operating activities related to product sales and research and development contract revenue as our primary source of working capital for the current and prior yearprior-year quarters. Net cash provided by operating activities was $9,098,330$9,351,238 for the first ninesix months of fiscal 2022 and $8,531,0682023 compared to $6,458,196 for the first ninesix months of fiscal 2021.2022.

 

Accounts receivable increased by $1,073,922$1,155,585 during the first ninesix months of fiscal 20222023 primarily due to the timing of sales to and payments from customers.increased product sales.

Prepaid expenses and other assets increased by $435,067 due to the timing of estimated tax payments.
 

Inventories increased $466,898$706,214 due primarily to our decisions to increase work in process in order to mitigate longer vendor lead-times.

 

Accounts payable and accrued expenses increased $890,822 due primarily due to a $1,504,462 increase in accrued expenses partially offset by a $544,272 decrease in accounts payable and a $69,368 net decrease in current and long-term operating lease liabilities. The increase in accrued expenses was due to increases in income taxes payable and deferred revenue. The decrease in accounts payable was due to the timing of vendor payments.

Investing Activities

Cash providedused by investing activities during the ninesix months ended December 31, 2021September 30, 2022 consisted of $4,000,000$25,381,057 of  marketable securities purchases and $24,500 of fixed asset purchases, partially offset by $18,750,000 in proceeds from maturities of marketable securities partially offset by $58,317 in capital expenditures. Capital expendituresand the receipt of a $100,000 tenant improvement allowance. Fixed asset purchases can vary from quarter to quarter depending on our needs and equipment purchasing opportunities. We have ordered several pieces ofadditional new production equipment to increase our production capacity. Therefore we currently expect significantly more capital expendituresfixed asset purchases during fiscal 20222023 than the $62,727$484,579 we invested in fiscal 2021.2022.

 

Financing Activities

Cash used in financing activities during the ninesix months ended December 31, 2021September 30, 2022 consisted of $14,499,696$9,661,652 of cash dividends paid to shareholders. In addition to cash dividends to shareholders paid in first nine monthssecond quarter of fiscal 2022,2023, on JanuaryOctober 19, 2022 we announced that our Board had declared a cash dividend of $1.00 per share of Common Stock, or $4,833,714$4,830,826 based on shares outstanding as of JanuaryOctober 14, 2022, to be paid February 28,November 30, 2022. We plan to fund dividends through cash provided by operating activities and proceeds from maturities of marketable securities. All future dividends will be subject to Board approval and subject to the company’s results of operations, cash and marketable security balances, estimates of future cash requirements, and other factors the Board may deem relevant. Furthermore, dividends may be modified or discontinued at any time without notice.

 

We currently believe our working capital and cash generated from operations will be adequate for our needs at least for the next 12 months.

16

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

Management, with the participation of the Chief Executive Officer and PrincipalChief Financial Officer, has performed an evaluation of our disclosure controls and procedures that are defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this Report. This evaluation included consideration of the controls, processes, and procedures that are designed to ensure that information required to be disclosed by us in the reports we file under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Although there have been changes in personnel involved in our controls, processes, and procedures, our management concluded that, as of December 31, 2021,September 30, 2022, our disclosure controls and procedures were effective.

 

Changes in Internal Controls

During the quarter ended December 31, 2021,September 30, 2022, there was no change in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART IIOTHER INFORMATION

 

Item 1. Legal Proceedings.

In the ordinary course of business we may become involved in litigation. At this time we are not aware of any material pending or threatened legal proceedings or other proceedings contemplated by governmental authorities that we expect would have a material adverse impact on our future results of operation and financial condition.

 

Item 1A. Risk Factors.

There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2021 as updated in our Quarterly Report on Form 10-Q for the quarters ended June 30, 2021 and September 30, 2021.2022.

 

Item 4. Mine Safety Disclosures.


None.
 

17

 

Item 6. Exhibits. 

 

Exhibit #

Description

3131.1

Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).

  
31.2Certification by Joseph P. Schmitz pursuant to Rule 13a-14(a)/15d-14(a).

32

Certification by Daniel A. Baker pursuantPursuant to 18 U.S.C. Section 1350.906 of the Sarbanes-Oxley Act of 2002.

  

101.INS

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

  

101.SCH     

Inline XBRL Taxonomy Extension Schema Document

  

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

  

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

  

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

  

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

  

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

18

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  

NVE CORPORATION

 
  

 (Registrant)

 
  
  

JanuaryOctober 19, 2022

 

/s/ DANIEL A. BAKER 

 

Date

 

Daniel A. Baker

 
  

President and Chief Executive Officer,
and Principal Financial
Officer

 
  
  
October 19, 2022 /s/ JOSEPH P. SCHMITZ
DateJoseph P. Schmitz 
  
Chief Financial Officer 

 

19